Are you Dr. Rosenfeld?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
222 S Woods Mill Rd
Suite 610N
Chesterfield, MO 63017Phone+1 314-453-9300
Summary
- Dr. William Rosenfeld, MD is a board certified neurologist in Chesterfield, Missouri. He is currently licensed to practice medicine in Missouri, Minnesota, and Florida. He is affiliated with St. Luke's Hospital and Missouri Baptist Medical Center.
Education & Training
University of Miami/Jackson Health SystemResidency, Neurology, 1980 - 1983- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1979 - 1980
Texas Tech University Health Sciences Center School of MedicineClass of 1979
Certifications & Licensure
MO State Medical License 1987 - 2025
MN State Medical License 1984 - 1987
FL State Medical License 1980 - 1985- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Start of enrollment: 2010 Jun 01
- Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures Start of enrollment: 2011 Jul 06
- Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 27 citationsEvaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.Dorothée G.A. Kasteleijn-Nolst Trenité, Jacqueline A. French, Edouard Hirsch, Jean Paul Macher, Bernd U. Meyer
Epilepsy Research. 2007-05-01 - 17 citationsKv7 potassium channel activation with ICA‐105665 reduces photoparoxysmal EEG responses in patients with epilepsyDorothée G.A. Kasteleijn-Nolst Trenité, Victor Biton, Jacqueline A. French, Bassel Abou-Khalil, William E. Rosenfeld
Epilepsia. 2013-08-01 - 95 citationsCenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.Michael R. Sperling, Pavel Klein, Sami Aboumatar, Michael A. Gelfand, Jonathan J. Halford
Epilepsia. 2020-06-01
Press Mentions
Latest XCOPRI® (Cenobamate Tablets) CV Post-Hoc Analysis Presented at the 75th American Academy of Neurology Annual MeetingApril 17th, 2023- Epilepsia Publishes Two Post-Hoc Analyses from Long-Term Study of XCOPRI® (Cenobamate Tablets) CVOctober 12th, 2021
- Epilepsia Publishes Two Post-Hoc Analyses from Long-Term Study of XCOPRI® (Cenobamate Tablets) CVOctober 12th, 2021
- Join now to see all
